Quik M

General

Full name : Quik Maryka

First name : Maryka

Mail : Center for Health Sciences, SRI International, Menlo Park ,SRI International, 333 Ravenswood Ave, California 94025

Zip Code :

City :

Country : USA

Email : maryka.quik@sri.com

Phone : 1-650-859-6112

Fax : 1-650-859-5099

Website : \/\/www.sri.com\/about\/people\/maryka-quik

Directory :

References (63)

Title : Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease - Quik_2015_Biochem.Pharmacol_97(4)_399
Author(s) : Quik M , Zhang D , McGregor M , Bordia T
Ref : Biochemical Pharmacology , 97 :399 , 2015
PubMedID: 26093062

Title : Poster: Antidyskinetic effect of the novel alpha7 nicotinic receptor agonist ABT-126 in parkinsonian monkeys -
Author(s) : McGregor M , Danhui Zhang D , Tanuja Bordia T , Perez XA , Decker MW , Quik M
Ref : Biochemical Pharmacology , 97 :629 , 2015
PubMedID:

Title : Poster: Striatal cholinergic interneurons regulate L-dopa-induced dyskinesias -
Author(s) : Bordia T , Xiomara Perez XA , Zhang D , Quik M
Ref : Biochemical Pharmacology , 97 :630 , 2015
PubMedID:

Title : Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawal - Perez_2015_Pharmacol.Res.Perspect_3_e00105
Author(s) : Perez XA , Khroyan TV , McIntosh JM , Quik M
Ref : Pharmacol Res Perspect , 3 :e00105 , 2015
PubMedID: 25692023

Title : Obituary of Theodore L. Sourkes, PhD, FRSC, OC -
Author(s) : Young S , Quik M , Almazan G , Ekker M
Ref : J Psychiatry Neurosci , 40 :214 , 2015
PubMedID: 25903035

Title : Evidence for a role for alpha6( *) nAChRs in l-dopa-induced dyskinesias using Parkinsonian alpha6( *) nAChR gain-of-function mice - Bordia_2015_Neurosci_295_187
Author(s) : Bordia T , McGregor M , McIntosh JM , Drenan RM , Quik M
Ref : Neuroscience , 295 :187 , 2015
PubMedID: 25813704

Title : The alpha7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions - Bordia_2015_Exp.Neurol_263_277
Author(s) : Bordia T , McGregor M , Papke RL , Decker MW , McIntosh JM , Quik M
Ref : Experimental Neurology , 263 :277 , 2015
PubMedID: 25261754

Title : Role for the nicotinic cholinergic system in movement disorders\; therapeutic implications - Quik_2014_Pharmacol.Ther_144_50
Author(s) : Quik M , Zhang D , Perez XA , Bordia T
Ref : Pharmacol Ther , 144 :50 , 2014
PubMedID: 24836728

Title : The alpha7 nicotinic receptor agonist ABT-107 decreases L-Dopa-induced dyskinesias in parkinsonian monkeys - Zhang_2014_J.Pharmacol.Exp.Ther_351_25
Author(s) : Zhang D , McGregor M , Decker MW , Quik M
Ref : Journal of Pharmacology & Experimental Therapeutics , 351 :25 , 2014
PubMedID: 25034405

Title : ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease - Zhang_2014_Mov.Disord_29_508
Author(s) : Zhang D , Bordia T , McGregor M , McIntosh JM , Decker MW , Quik M
Ref : Movement Disorders , 29 :508 , 2014
PubMedID: 24515328

Title : Nicotinic Receptor Agonists Reduce L-DOPA-Induced Dyskinesias in a Monkey Model of Parkinson's Disease - Zhang_2013_J.Pharmacol.Exp.Ther_347_225
Author(s) : Zhang D , Mallela A , Sohn D , Carroll FI , Bencherif M , Letchworth SR , Quik M
Ref : Journal of Pharmacology & Experimental Therapeutics , 347 :225 , 2013
PubMedID: 23902940

Title : Long-term nicotine treatment down-regulates alpha6beta2* nicotinic receptor expression and function in nucleus accumbens - Perez_2013_J.Neurochem_127_762
Author(s) : Perez XA , McIntosh JM , Quik M
Ref : Journal of Neurochemistry , 127 :762 , 2013
PubMedID: 23992036

Title : Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice - Quik_2013_Biochem.Pharmacol_86(8)_1153
Author(s) : Quik M , Campos C , Grady SR
Ref : Biochemical Pharmacology , 86 :1153 , 2013
PubMedID: 23831952

Title : Alpha4beta2 nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats - Quik_2013_Neuropharmacol_71_191
Author(s) : Quik M , Campos C , Bordia T , Strachan JP , Zhang J , McIntosh JM , Letchworth SR , Jordan K
Ref : Neuropharmacology , 71 :191 , 2013
PubMedID: 23583932

Title : Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function - Quik_2013_Neurobiol.Dis_50_30
Author(s) : Quik M , Mallela A , Chin M , McIntosh JM , Perez XA , Bordia T
Ref : Neurobiol Dis , 50 :30 , 2013
PubMedID: 23009753

Title : Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease - Quik_2013_Mov.Disord_28_1398
Author(s) : Quik M , Mallela A , Ly J , Zhang D
Ref : Movement Disorders , 28 :1398 , 2013
PubMedID: 23836409

Title : The nicotine-mediated decline in l-dopa-induced dyskinesias is associated with a decrease in striatal dopamine release - Bordia_2013_J.Neurochem_125_291
Author(s) : Bordia T , McIntosh JM , Quik M
Ref : Journal of Neurochemistry , :291 , 2013
PubMedID: 23373725

Title : Long-term nicotine exposure depresses dopamine release in nonhuman primate nucleus accumbens - Perez_2012_J.Pharmacol.Exp.Ther_342_335
Author(s) : Perez XA , Ly J , McIntosh JM , Quik M
Ref : Journal of Pharmacology & Experimental Therapeutics , 342 :335 , 2012
PubMedID: 22562772

Title : Role for alpha6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice - Quik_2012_Neuropharmacol_63_450
Author(s) : Quik M , Park KM , Hrachova M , Mallela A , Huang LZ , McIntosh JM , Grady SR
Ref : Neuropharmacology , 63 :450 , 2012
PubMedID: 22579614

Title : Nicotine as a potential neuroprotective agent for Parkinson's disease - Quik_2012_Mov.Disord_27_947
Author(s) : Quik M , Perez XA , Bordia T
Ref : Movement Disorders , 27 :947 , 2012
PubMedID: 22693036

Title : Varenicline is a potent partial agonist at alpha6beta2* nicotinic acetylcholine receptors in rat and monkey striatum - Bordia_2012_J.Pharmacol.Exp.Ther_342_327
Author(s) : Bordia T , Hrachova M , Chin M , McIntosh JM , Quik M
Ref : Journal of Pharmacology & Experimental Therapeutics , 342 :327 , 2012
PubMedID: 22550286

Title : Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats - Bordia_2012_J.Pharmacol.Exp.Ther_340_612
Author(s) : Bordia T , McIntosh JM , Quik M
Ref : Journal of Pharmacology & Experimental Therapeutics , 340 :612 , 2012
PubMedID: 22144565

Title : Poster: Comparison of binding and functional activity profiles for a set of nicotinic acetylcholine receptor ligands across multiple alpha6* expression systems -
Author(s) : Breining SR , Hepler C , Whiteaker P , Quik M , Grady SR , Yohannes D
Ref : Biochemical Pharmacology , 82 :1024 , 2011
PubMedID:

Title : Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats - Huang_2011_Neuropharmacol_60_861
Author(s) : Huang LZ , Campos C , Ly J , Ivy Carroll F , Quik M
Ref : Neuropharmacology , 60 :861 , 2011
PubMedID: 21232546

Title : Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors - Huang_2011_J.Pharmacol.Exp.Ther_338_932
Author(s) : Huang LZ , Grady SR , Quik M
Ref : Journal of Pharmacology & Experimental Therapeutics , 338 :932 , 2011
PubMedID: 21665941

Title : Focus on alpha4beta2* and alpha6beta2* nAChRs for Parkinson's Disease Therapeutics - Perez_2011_Mol.Cell.Pharmacol_3_1
Author(s) : Perez XA , Quik M
Ref : Mol Cell Pharmacol , 3 :1 , 2011
PubMedID: 21499569

Title : Role of alpha6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders - Quik_2011_Biochem.Pharmacol_82(8)_873
Author(s) : Quik M , Perez XA , Grady SR
Ref : Biochemical Pharmacology , 82 :873 , 2011
PubMedID: 21684266

Title : Targeting nicotinic receptors for Parkinson's disease therapy - Quik_2011_CNS.Neurol.Disord.Drug.Targets_10_651
Author(s) : Quik M , Bordia T , Huang L , Perez XA
Ref : CNS Neurol Disord Drug Targets , 10 :651 , 2011
PubMedID: 21838678

Title : alpha6beta2* and alpha4beta2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease - Quik_2011_Pharmacol.Rev_63_938
Author(s) : Quik M , Wonnacott S
Ref : Pharmacol Rev , 63 :938 , 2011
PubMedID: 21969327

Title : Chronic nicotine treatment increases nAChRs and microglial expression in monkey substantia nigra after nigrostriatal damage - Quik_2010_J.Mol.Neurosci_40_105
Author(s) : Quik M , Campos C , Parameswaran N , Langston JW , McIntosh JM , Yeluashvili M
Ref : Journal of Molecular Neuroscience , 40 :105 , 2010
PubMedID: 19685015

Title : alpha6ss2* and alpha4ss2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease - Perez_2010_Mol.Pharmacol_78_971
Author(s) : Perez XA , Bordia T , McIntosh JM , Quik M
Ref : Molecular Pharmacology , 78 :971 , 2010
PubMedID: 20732972

Title : Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization - Bordia_2010_J.Pharmacol.Exp.Ther_333_929
Author(s) : Bordia T , Campos C , McIntosh JM , Quik M
Ref : Journal of Pharmacology & Experimental Therapeutics , 333 :929 , 2010
PubMedID: 20200117

Title : Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys - Huang_2009_J.Neurochem_109_826
Author(s) : Huang LZ , Parameswaran N , Bordia T , McIntosh JM , Quik M
Ref : Journal of Neurochemistry , 109 :826 , 2009
PubMedID: 19250334

Title : Prominent role of alpha3\/alpha6beta2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatment - Perez_2009_Mol.Pharmacol_75_938
Author(s) : Perez XA , O'Leary KT , Parameswaran N , McIntosh JM , Quik M
Ref : Molecular Pharmacology , 75 :938 , 2009
PubMedID: 19144785

Title : Multiple roles for nicotine in Parkinson's disease - Quik_2009_Biochem.Pharmacol_78(7)_677
Author(s) : Quik M , Huang LZ , Parameswaran N , Bordia T , Campos C , Perez XA
Ref : Biochemical Pharmacology , 78 :677 , 2009
PubMedID: 19433069

Title : Poster: nAChR agonists reduce l-dopa-induced dyskinesias in parkinsonian rats -
Author(s) : Quik M , Huang LZ , Lee Y , Carroll IF , Parameswaran N
Ref : Biochemical Pharmacology , 78 :922 , 2009
PubMedID:

Title : Nicotine neuroprotection against nigrostriatal damage: importance of the animal model - Quik_2007_Trends.Pharmacol.Sci_28_229
Author(s) : Quik M , O'Neill M , Perez XA
Ref : Trends in Pharmacological Sciences , 28 :229 , 2007
PubMedID: 17412429

Title : Guidelines on nicotine dose selection for in vivo research - Matta_2007_Psychopharmacology.(Berl)_190_269
Author(s) : Matta SG , Balfour DJ , Benowitz NL , Boyd RT , Buccafusco JJ , Caggiula AR , Craig CR , Collins AC , Damaj MI , Donny EC , Gardiner PS , Grady SR , Heberlein U , Leonard SS , Levin ED , Lukas RJ , Markou A , Marks MJ , McCallum SE , Parameswaran N , Perkins KA , Picciotto MR , Quik M , Rose JE , Rothenfluh A , Schafer WR , Stolerman IP , Tyndale RF , Wehner JM , Zirger JM
Ref : Psychopharmacology (Berl) , 190 :269 , 2007
PubMedID: 16896961

Title : Nicotinic receptors as CNS targets for Parkinson's disease - Quik_2007_Biochem.Pharmacol_74(8)_1224
Author(s) : Quik M , Bordia T , O'Leary K
Ref : Biochemical Pharmacology , 74 :1224 , 2007
PubMedID: 17631864

Title : Nicotine partially protects against paraquat-induced nigrostriatal damage in mice\; link to alpha6beta2* nAChRs - Khwaja_2007_J.Neurochem_100_180
Author(s) : Khwaja M , McCormack A , McIntosh JM , Di Monte DA , Quik M
Ref : Journal of Neurochemistry , 100 :180 , 2007
PubMedID: 17227438

Title : Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys - Quik_2007_Ann.Neurol_62_588
Author(s) : Quik M , Cox H , Parameswaran N , O'Leary K , Langston JW , Di Monte D
Ref : Annals of Neurology , 62 :588 , 2007
PubMedID: 17960553

Title : Nigrostriatal damage preferentially decreases a subpopulation of alpha6beta2* nAChRs in mouse, monkey, and Parkinson's disease striatum - Bordia_2007_Mol.Pharmacol_72_52
Author(s) : Bordia T , Grady SR , McIntosh JM , Quik M
Ref : Molecular Pharmacology , 72 :52 , 2007
PubMedID: 17409284

Title : Increases in alpha4* but not alpha3*\/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment - McCallum_2006_J.Neurochem_96_1028
Author(s) : McCallum SE , Parameswaran N , Bordia T , Fan H , Tyndale RF , Langston JW , McIntosh JM , Quik M
Ref : Journal of Neurochemistry , 96 :1028 , 2006
PubMedID: 16412091

Title : Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates - Quik_2006_J.Neurosci_26_4681
Author(s) : Quik M , Chen L , Parameswaran N , Xie X , Langston JW , McCallum SE
Ref : Journal of Neuroscience , 26 :4681 , 2006
PubMedID: 16641249

Title : Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates - Quik_2006_J.Neurochem_98_1866
Author(s) : Quik M , Parameswaran N , McCallum SE , Bordia T , Bao S , McCormack A , Kim A , Tyndale RF , Langston JW , Di Monte DA
Ref : Journal of Neurochemistry , 98 :1866 , 2006
PubMedID: 16882311

Title : Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA - Quik_2005_Mol.Pharmacol_67_32
Author(s) : Quik M , Vailati S , Bordia T , Kulak JM , Fan H , McIntosh JM , Clementi F , Gotti C
Ref : Molecular Pharmacology , 67 :32 , 2005
PubMedID: 15470079

Title : Decrease in alpha3*\/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage - McCallum_2005_Mol.Pharmacol_68_737
Author(s) : McCallum SE , Parameswaran N , Bordia T , McIntosh JM , Grady SR , Quik M
Ref : Molecular Pharmacology , 68 :737 , 2005
PubMedID: 15933214

Title : Long-term nicotine treatment decreases striatal alpha 6* nicotinic acetylcholine receptor sites and function in mice - Lai_2005_Mol.Pharmacol_67_1639
Author(s) : Lai A , Parameswaran N , Khwaja M , Whiteaker P , Lindstrom JM , Fan H , McIntosh JM , Grady SR , Quik M
Ref : Molecular Pharmacology , 67 :1639 , 2005
PubMedID: 15681595

Title : Selective recovery of striatal 125I-alpha-conotoxinmii nicotinic receptors after nigrostriatal damage in monkeys - Lai_2004_Neurosci_127_399
Author(s) : Lai A , Sum J , Fan H , McIntosh JM , Quik M
Ref : Neuroscience , 127 :399 , 2004
PubMedID: 15262330

Title : Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites - Kulak_2002_Mol.Pharmacol_61_230
Author(s) : Kulak JM , McIntosh JM , Quik M
Ref : Molecular Pharmacology , 61 :230 , 2002
PubMedID: 11752225

Title : Differential nicotinic receptor expression in monkey basal ganglia: effects of nigrostriatal damage - Quik_2002_Neurosci_112_619
Author(s) : Quik M , Polonskaya Y , McIntosh JM , Kulak JM
Ref : Neuroscience , 112 :619 , 2002
PubMedID: 12074903

Title : Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey - Quik_2001_J.Neurosci_21_5494
Author(s) : Quik M , Polonskaya Y , Kulak JM , McIntosh JM
Ref : Journal of Neuroscience , 21 :5494 , 2001
PubMedID: 11466420

Title : Nitric oxide is involved in acetylcholinesterase inhibitor-induced myopathy in rats - Jeyarasasingam_2000_J.Pharmacol.Exp.Ther_295_314
Author(s) : Jeyarasasingam G , Yeluashvili M , Quik M
Ref : Journal of Pharmacology & Experimental Therapeutics , 295 :314 , 2000
PubMedID: 10991996

Title : Nicotinic receptors and Parkinson's disease - Quik_2000_Eur.J.Pharmacol_393_223
Author(s) : Quik M , Jeyarasasingam G
Ref : European Journal of Pharmacology , 393 :223 , 2000
PubMedID: 10771017

Title : Tacrine, a reversible acetylcholinesterase inhibitor, induces myopathy - Jeyarasasingam_2000_Neuroreport_11_1173
Author(s) : Jeyarasasingam G , Yeluashvili M , Quik M
Ref : Neuroreport , 11 :1173 , 2000
PubMedID: 10817586

Title : Differential alterations in nicotinic receptor alpha6 and beta3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration - Quik_2000_Neurosci_100_63
Author(s) : Quik M , Polonskaya Y , Gillespie A , G KL , Langston JW
Ref : Neuroscience , 100 :63 , 2000
PubMedID: 10996459

Title : International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits -
Author(s) : Lukas RJ , Changeux JP , Le Novere N , Albuquerque EX , Balfour DJ , Berg DK , Bertrand D , Chiappinelli VA , Clarke PB , Collins AC , Dani JA , Grady SR , Kellar KJ , Lindstrom JM , Marks MJ , Quik M , Taylor P , Wonnacott S
Ref : Pharmacol Rev , 51 :397 , 1999
PubMedID: 10353988

Title : Production of polyclonal antisera that recognize and distinguish between the extracellular domains of neuronal nicotinic acetylcholine receptor subunits - Neff_1995_J.Neurochem_64_332
Author(s) : Neff S , Dineley-Miller K , Char D , Quik M , Patrick J
Ref : Journal of Neurochemistry , 64 :332 , 1995
PubMedID: 7798929

Title : Letter of retraction -
Author(s) : Quik M , Afar R , Clarke PB , Cohen R , Goldstein G
Ref : Neuroscience , 59 :789 , 1994
PubMedID: 8008220

Title : Thymopoietin, a polypeptide ligand for the alpha-bungarotoxin binding site in brain: an autoradiographic study Retraction in: Quik M, Afar R, Clarke PB, Cohen R, Goldstein G. Neuroscience. 1994 Apr\;59(3):789. - Afar_1992_Neurosci_48_641
Author(s) : Afar R , Clarke PB , Goldstein G , Quik M
Ref : Neuroscience , 48 :641 , 1992
PubMedID: 1603334

Title : Monoclonal antibodies against alpha-bungarotoxin - Quik_1990_Neurochem.Int_16_163
Author(s) : Quik M , Geertsen S , Kenigsberg RL , Cuello AC
Ref : Neurochem Int , 16 :163 , 1990
PubMedID: 20504554

Title : Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptors - Boksa_1989_Eur.J.Pharmacol_173_93
Author(s) : Boksa P , Quik M , Mitchell JB , Collier B , O'Neil W , Quirion R
Ref : European Journal of Pharmacology , 173 :93 , 1989
PubMedID: 2606158

Title : Activity of aldehyde dehydrogenase, aldehyde reductase, and acetylcholine esterase in striatum of rats bearing electrolytic lesions of the medial forebrain bundle -
Author(s) : Duncan RJ , Sourkes TL , Dubrovsky BO , Quik M
Ref : Journal of Neurochemistry , 24 :143 , 1975
PubMedID: 234146